MXCT (MaxCyte, Inc. Common Stock) Stock Analysis - Analyst Ratings

MaxCyte, Inc. Common Stock (MXCT) is a publicly traded Healthcare sector company. As of May 21, 2026, MXCT trades at $1.07 with a market cap of $113.55M and a P/E ratio of -2.49. MXCT moved +1.44% today. Year to date, MXCT is -30.97%; over the trailing twelve months it is -50.92%. Its 52-week range spans $0.64 to $5.20. Analyst consensus is buy with an average price target of $4.00. Rallies surfaces MXCT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate MXCT?

5 analysts cover MXCT: 0 strong buy, 3 buy, 2 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $4.00.

MXCT Key Metrics

Key financial metrics for MXCT
MetricValue
Price$1.07
Market Cap$113.55M
P/E Ratio-2.49
EPS$-0.42
Dividend Yield0.00%
52-Week High$5.20
52-Week Low$0.64
Volume0
Avg Volume0
Revenue (TTM)$33.03M
Net Income$-44.63M
Gross Margin81.16%

MXCT Analyst Consensus

5 analysts cover MXCT: 0 strong buy, 3 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $4.00.

Latest MXCT News

Recent MXCT Insider Trades

  • Swirsky Douglas J sold 10.14K (~$8.27K) on Mar 17, 2026.
  • Swirsky Douglas J bought 50.00K (~$64.50K) on Aug 13, 2025.
  • Masoud Maher bought 75.00K (~$102.92K) on Aug 13, 2025.

Common questions about MXCT

What do analysts rate MXCT?
5 analysts cover MXCT: 0 strong buy, 3 buy, 2 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $4.00.
Does Rallies show MXCT price targets?
Yes. Rallies tracks MXCT analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is MXCT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for MXCT. It does not provide personalized investment advice.
MXCT

MXCT